Similarly, in a large series of breast cancers, a positive correlation was found between the expression of immunosuppressive checkpoint markers (PD-1, PDL1, CTLA4, and FOXP3) and the expression of proimmune markers, suggestive of a feedback activation of immunosuppressive pathways as part of the immune reaction [16]. Here, CD274 is linked to breast carcinoma.